The Joint Corp. (NASDAQ:JYNT – Get Free Report) was the recipient of a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 454,700 shares, a decline of 14.8% from the June 30th total of 533,600 shares. Based on an average trading volume of 64,200 shares, the days-to-cover ratio is currently 7.1 days.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on JYNT shares. B. Riley increased their price objective on shares of Joint from $12.00 to $20.00 and gave the company a “buy” rating in a research report on Monday, May 6th. Roth Mkm reaffirmed a “buy” rating and issued a $16.00 price objective (up previously from $13.00) on shares of Joint in a report on Friday, May 3rd. Finally, StockNews.com raised Joint from a “hold” rating to a “buy” rating in a report on Monday, May 6th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Joint has a consensus rating of “Moderate Buy” and a consensus price target of $22.00.
Joint Stock Performance
Joint (NASDAQ:JYNT – Get Free Report) last released its earnings results on Thursday, May 2nd. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.09. Joint had a positive return on equity of 3.94% and a negative net margin of 9.24%. The company had revenue of $29.72 million for the quarter, compared to the consensus estimate of $29.17 million. On average, analysts expect that Joint will post 0.2 EPS for the current fiscal year.
Institutional Investors Weigh In On Joint
Several hedge funds and other institutional investors have recently added to or reduced their stakes in JYNT. Avondale Wealth Management increased its stake in Joint by 15.8% in the 2nd quarter. Avondale Wealth Management now owns 22,000 shares of the company’s stock worth $309,000 after buying an additional 3,000 shares in the last quarter. Ancora Advisors LLC lifted its holdings in Joint by 105.0% in the 1st quarter. Ancora Advisors LLC now owns 99,212 shares of the company’s stock worth $1,296,000 after purchasing an additional 50,815 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in Joint by 5.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company’s stock worth $229,000 after purchasing an additional 837 shares during the period. First Foundation Advisors grew its holdings in Joint by 18.8% during the 1st quarter. First Foundation Advisors now owns 209,301 shares of the company’s stock valued at $2,733,000 after buying an additional 33,104 shares in the last quarter. Finally, Russell Investments Group Ltd. raised its position in shares of Joint by 8.9% during the first quarter. Russell Investments Group Ltd. now owns 90,147 shares of the company’s stock valued at $1,177,000 after buying an additional 7,375 shares during the last quarter. 76.88% of the stock is owned by hedge funds and other institutional investors.
About Joint
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Featured Stories
- Five stocks we like better than Joint
- What is the Dow Jones Industrial Average (DJIA)?
- Survey: Top 175 Fittest Retirement Locations in America
- Investing in Travel Stocks Benefits
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- Stock Average Calculator
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.